Current Cancer Therapy Reviews
Country
United Arab Emirates
Middle East
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q4
└
Molecular Medicine
Q4
└
Oncology
Q4
Publisher
SJR 2025
0.214
Q4
SJR Score
H-Index
20
Citations / Doc (2yr)
1.06
Total Docs. (latest)
103
Total Citations (3yr)
121
Publication type
Journals
ISSN
18756301, 15733947
Coverage
2006-2026
Journal Rank
#21,124
Subject Categories
Cancer Research
Q4
Molecular Medicine
Q4
Oncology
Q4
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 103 |
| Total Docs. (3 years) | 124 |
| Total Refs. | 9,638 |
| Total Citations (3 years) | 121 |
| Citable Docs. (3 years) | 120 |
| Citations / Doc. (2 years) | 1.06 |
| Ref. / Doc. | 93.57 |
| % Female | 42.6% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Current Cancer Therapy Reviews?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Current Cancer Therapy Reviews has an SJR of 0.214 and is ranked Q4.
What is the SJR and quartile of Current Cancer Therapy Reviews?
Current Cancer Therapy Reviews has an SJR (SCImago Journal Rank) of 0.214 and its best quartile is Q4.
What is the H-index of Current Cancer Therapy Reviews?
The H-index of Current Cancer Therapy Reviews is 20, meaning 20 of its articles have each been cited at least 20 times.
Is Current Cancer Therapy Reviews indexed in Scopus?
Yes. Current Cancer Therapy Reviews is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.